基础化工行业 行业研究 | 行业周报 磷化工战略重要性受到市场认知 核心观点 投资建议与投资标的 ⚫ 我们持续看好化工各子行业景气复苏机遇，如 MDI 龙头：万华化学(600309，买 入) ；PVC 行业，相关企业包括：中泰化学(002092，未评级)、新疆天业(600075， 未评级)、氯碱化工(600618，未评级)、天原股份(002386，未评级)。炼化行业我们 推荐相关龙头企业中国石化(600028，买入)、荣盛石化(002493，买入)、恒力石化 (600346，买入)。农化产业链我们看好技术服务为导向的龙头的增长机会，植调剂 龙头国光股份(002749，买入)；复合肥龙头，相关企业新洋丰(000902，买入)、史 丹利(002588，未评级)、云图控股(002539，未评级)；农药制剂出海龙头润丰股份 (301035，买入)。以及景气度持续性受储能高速增长拉动的磷化工中相关标的包 括：川恒股份(002895，未评级)、云天化(600096，未评级)等。草酸行业中，建议 关注：华鲁恒升(600426，买入)、华谊集团(600623，买入)、万凯新材(301216，买 入)。 风险提示 ⚫ 需求不及 ...

国光股份（002749.SZ）2月26日在投资者互动平台表示，公司现有产能主要是IPO募投项目投产产能以 及近几年并购行业内的公司后增加的产能，产能正逐步释放。公司在建产能主要系原药产能和水溶肥产 能，是补短板、强基础的战略决策。新增产能能保证核心原药的自主供应、优化产业链，支撑作物全程 方案扩张，匹配公司长期增长需求。 每经AI快讯，有投资者在投资者互动平台提问：根据2024年报显示，公司的农药原药和农药制剂产能 利用率分别为56.15%和31.15%，为何还在建设新产能？ （记者 张明双） ...

美邦股份上演天地板！刚走出4连板就突发跳水，究竟是逻辑兑现，还是收割游戏？ 春节前夕，化工板块集体回暖，磷化工概念成为焦点。美邦股份凭借与产业链的关联，被市场挖掘，悄 然走出3连板，成为板块中的"潜力黑马"。 到了2月24日，行情持续发酵，叠加游资入场接力，美邦股份直接高开封板，顺利达成4连板，股价累计 涨幅达46.43%。一时间，游资抢筹、散户跟风，市场情绪被彻底点燃。 而估值更是令人咋舌。美邦股份滚动市盈率高达143倍，而行业均值仅为34倍，泡沫已肉眼可见。公司 接连发布风险提示，直言无重大利好、业绩下滑、估值过高，却仍挡不住资金的炒作热情。 回看这4连板，本质是一场概念炒作：春节前，借势化工板块热度与磷化工概念顺势走出3连板；24日的 第4板，则是游资集中买入的典型表现。 2月24日的龙虎榜清晰显示，买入席位中游资云集，正是他们的集中进场，将股价推至涨停。 今天的天地板，则意味着游资离场、泡沫破裂。4连板积累的巨大获利盘集中涌出，1.2万手卖单瞬间砸 盘，股价从天堂跌落地狱，跟风散户被挂在山顶，成为最后的买单者。 美邦股份的暴涨，始于概念沾边、终于情绪退潮；天地板的暴跌，则是业绩不支撑、估值泡沫破裂的必 ...

Group 1 - The core viewpoint of the news is that Zhongqi Co., Ltd. has experienced a stock price increase of 5.34% on February 11, reaching 7.10 yuan per share, with a total market capitalization of 3.387 billion yuan [1] - Zhongqi Co., Ltd. is primarily engaged in the development, production, and sales of pesticides and intermediates, with its main revenue sources being pesticide raw materials (71.00%), pesticide formulations (11.57%), trading income (10.92%), pesticide intermediates (5.45%), and others (1.05%) [1] - The company has seen a cumulative stock price increase of 4.66% over the past three days, with a trading volume of 85.9723 million yuan and a turnover rate of 3.60% [1] Group 2 - Among the top ten circulating shareholders of Zhongqi Co., Ltd., the Jin Yuan Shun An Fund has a new entry with the Jin Yuan Shun An Yuan Qi Flexible Allocation Mixed Fund (004685), holding 2.083 million shares, accounting for 0.61% of the circulating shares [2] - The Jin Yuan Shun An Yuan Qi Flexible Allocation Mixed Fund has achieved a year-to-date return of 7.6% and a one-year return of 53.98%, ranking 2666 out of 8884 and 1234 out of 8127 respectively [2] - The fund manager, Miao Weibin, has a tenure of 9 years and 60 days, with the fund's total asset size being 1.564 billion yuan and a best return of 616.37% during his tenure [2]

Investment Rating - The industry investment rating is maintained as "Positive" [5] Core Viewpoints - The agricultural chemical industry is entering a period of layout opportunities, driven by the increasing importance of food security amid geopolitical fluctuations. The focus is on enhancing planting efficiency through technological empowerment [8] - The report emphasizes the growth potential of leading companies in the agricultural chemical sector, particularly those focused on technology services, including plant growth regulators, compound fertilizers, and pesticide formulations [3][8] - The report highlights the recovery opportunities in various sub-sectors of the chemical industry, including MDI, PVC, and refining, with specific companies recommended for investment [3][8] Summary by Relevant Sections Agricultural Chemical Sector - The report identifies growth opportunities in the agricultural chemical sector, particularly for companies that provide technology-driven services. Key areas include: 1. Plant growth regulators, which are characterized by low usage, high effectiveness, and cost efficiency, are seen as essential for modern agriculture [8] 2. Compound fertilizers are crucial for providing precise nutrient ratios to crops, with room for growth in China's compound fertilizer application rates compared to developed countries [8] 3. The potential for Chinese pesticide formulation companies to expand internationally, breaking the monopoly of traditional multinational corporations [8] Chemical Industry Recovery - The report notes a positive outlook for the recovery of various chemical sub-sectors, including: - MDI leader Wanhua Chemical (600309, Buy) [3] - PVC industry players such as Zhongtai Chemical (002092, Not Rated) and Xinjiang Tianye (600075, Not Rated) [3] - Refining sector leaders like Sinopec (600028, Buy) and Rongsheng Petrochemical (002493, Buy) [3] - The report anticipates continued price increases for high-energy products, particularly in the PVC sector, due to supply constraints and structural demand shifts [8]

Core Viewpoint - The performance of Runfeng Co., Ltd. has significantly improved, necessitating a reassessment of the value of its formulation exports, with expected net profit attributable to shareholders projected at 1.03-1.17 billion yuan, representing a year-on-year increase of 129% to 160% [1] Financial Performance - The company anticipates a net profit of 140-280 million yuan for Q4 2025, reflecting a year-on-year growth of 9% to 119%, but a quarter-on-quarter decline of 62% to 25% [1] - The overall performance for 2025 is expected to show substantial improvement due to the gradual recovery of procurement demand and the bottoming out of product prices [1] Market Outlook - Looking ahead to 2026, the demand for pesticides and product prices are expected to improve further compared to 2025, particularly with seasonal orders likely to exceed expectations, driving accelerated recovery in market conditions [1] - As a leading domestic exporter of formulations, the company is continuously enhancing its global marketing network, which will strengthen its profitability as the ModelC business matures and its market share increases [1] Strategic Positioning - The company is well-positioned to expand into high-barrier, high-value markets such as North America and the European Union, which will contribute to sustained improvements in profitability [1] - The industry is experiencing a steady recovery in market conditions, with ongoing strategic planning and continuous improvement in operational quality [1]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company is expected to achieve revenue of 145.5-147.5 billion yuan for 2025, representing a year-over-year growth of 9% to 11%. The net profit attributable to shareholders is projected to be between 10.3-11.7 billion yuan, indicating a significant year-over-year increase of 129% to 160% [4] - The company has seen a recovery in procurement demand since 2025, with most product prices reaching a bottom. The global pesticide market is gradually normalizing, leading to substantial improvements in the company's performance [6] - The company is enhancing its global marketing network, and the value of its overseas formulation business needs to be reassessed. The cancellation of certain export VAT rebates is expected to create a "rush to export" scenario before April 1, 2026, which may boost demand for various products [6] Financial Data and Profit Forecast - The total revenue for 2025 is estimated at 14,645 million yuan, with a year-over-year growth rate of 10.1%. The net profit attributable to shareholders is forecasted to be 1,148 million yuan, reflecting a year-over-year growth of 155.1% [5] - The company’s gross margin is expected to improve, with projections of 21.9% for 2025 and 22.6% for 2026. The return on equity (ROE) is anticipated to be 14.8% in 2025 and 15.8% in 2026 [5] - The current market capitalization corresponds to a price-to-earnings (PE) ratio of 19 for 2025, 16 for 2026, and 13 for 2027, indicating a favorable valuation as the industry recovers [6]

Group 1 - The core viewpoint of the news is that Hailier's stock performance and financing activities indicate a low level of investor confidence, with a notable decrease in financing net purchases and a high level of short selling [1][2] Group 2 - As of January 16, Hailier's stock price fell by 1.59%, with a trading volume of 32.45 million yuan. The financing buy amount was 3.21 million yuan, while the financing repayment was 3.76 million yuan, resulting in a net financing buy of -0.55 million yuan [1] - The total margin trading balance for Hailier as of January 16 was 98.38 million yuan, with the financing balance accounting for 2.23% of the circulating market value, which is below the 50th percentile level over the past year [1] - On the short selling side, Hailier repaid 8,700 shares on January 16, with no shares sold short, resulting in a short selling balance of 19.20 thousand yuan, which is above the 90th percentile level over the past year [1] Group 3 - As of September 30, Hailier had 13,000 shareholders, a decrease of 14.70% from the previous period, while the average circulating shares per person increased by 17.23% to 26,229 shares [2] - For the period from January to September 2025, Hailier reported operating revenue of 3.39 billion yuan, a year-on-year increase of 5.50%, and a net profit attributable to shareholders of 208 million yuan, up 6.15% year-on-year [2] - Hailier has distributed a total of 1.26 billion yuan in dividends since its A-share listing, with 680 million yuan distributed over the past three years [2] Group 4 - Among the top ten circulating shareholders as of September 30, 2025, the seventh largest is the "Zhaoshang Quantitative Selected Stock Fund" with 2.72 million shares, a new shareholder. The eighth largest is "Hong Kong Central Clearing Limited" with 2.25 million shares, a decrease of 1.83 million shares from the previous period [2]

Group 1 - The core viewpoint of the news is that Lier Chemical has shown significant stock performance and financial growth, with a notable increase in revenue and net profit year-on-year [2][3]. - As of January 16, Lier Chemical's stock price decreased by 2.03% to 14.95 CNY per share, with a total market capitalization of 11.967 billion CNY [1]. - The company has experienced a stock price increase of 14.56% year-to-date, with a 7.40% rise over the last five trading days and a 23.76% increase over the last 60 days [1]. Group 2 - For the period from January to September 2025, Lier Chemical achieved an operating revenue of 6.709 billion CNY, representing a year-on-year growth of 29.31%, and a net profit attributable to shareholders of 381 million CNY, which is a 189.07% increase compared to the previous year [2]. - The company has distributed a total of 1.496 billion CNY in dividends since its A-share listing, with 720 million CNY distributed over the last three years [3]. - As of September 30, 2025, Lier Chemical had 40,300 shareholders, a decrease of 4.20% from the previous period, while the average number of circulating shares per person increased by 4.39% to 19,842 shares [2].

Core Viewpoint - The cancellation of export tax rebates for certain pesticide raw materials, including glyphosate, starting April 1, 2026, will initially squeeze profits for related companies and increase product prices, but will ultimately drive industry upgrades and enhance product value [1][2]. Group 1: Policy Impact - The Ministry of Finance and the State Taxation Administration announced the cancellation of export tax rebates for several pesticide raw materials, including glyphosate, effective April 1, 2026 [2]. - The removal of export tax rebates is expected to pressure profit margins for glyphosate and other pesticide companies in the short term, while also leading to price increases due to heightened export demand and domestic spring planting preparations [3]. Group 2: Industry Dynamics - The cancellation of export tax rebates will force the elimination of outdated production capacity and encourage domestic glyphosate companies to upgrade to refined glyphosate and extend into downstream formulations, thereby increasing product value [3]. - The glyphosate market is currently experiencing tight supply and demand, with production expected to grow from 18,300 tons in 2020 to 120,400 tons by 2025, representing a 658.38% increase and an annual compound growth rate of 45.78% [3]. - The export rebate rate for pesticide formulations remains at 9%, and in 2024, China's pesticide formulation export value reached 61.36 billion yuan, surpassing raw material exports for the first time, with a share of 54.12% [3].